1. Home
  2. BHFAN vs RLAY Comparison

BHFAN vs RLAY Comparison

Compare BHFAN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

BHFAN

Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

N/A

Current Price

$12.89

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$10.36

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHFAN
RLAY
Founded
N/A
2015
Country
United States
United States
Employees
1400
N/A
Industry
Life Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BHFAN
RLAY
Price
$12.89
$10.36
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$14.50
AVG Volume (30 Days)
89.3K
2.3M
Earning Date
N/A
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$396.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.44
52 Week Low
$11.51
$1.78
52 Week High
$17.40
$11.43

Technical Indicators

Market Signals
Indicator
BHFAN
RLAY
Relative Strength Index (RSI) 29.04 60.91
Support Level $12.32 $9.06
Resistance Level $13.98 $11.43
Average True Range (ATR) 0.20 0.77
MACD -0.10 0.06
Stochastic Oscillator 2.56 56.56

Price Performance

Historical Comparison
BHFAN
RLAY

About BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: